Streetbeat News

Analyst Ratings

ULCC

Raymond James analyst Savanthi Syth has maintained an Outperform rating on Frontier Group Holdings (NASDAQ:ULCC), but lowered the price target from $12 to $9.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 12:00 pm

ALGT

Raymond James analyst Savanthi Syth has maintained an Outperform rating on Allegiant Travel (NASDAQ:ALGT), but lowered the price target from $145 to $118.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 11:58 am

GSK

PFE

SNY

The Centers for Disease Control and Prevention (CDC) has recommended Pfizer's bivalent RSVpreF vaccine (Abrysvo) for pregnant people to protect their newborns from severe RSV illness. This is the first RSV vaccine recommended by the CDC. The vaccine has been shown to reduce the risk of RSV hospitalization for babies by 57% in the first six months after birth. Pfizer and GSK are competing in the RSV vaccine market, which could exceed $10 billion by 2030. The FDA has also approved GSK's Arexvy and an RSV antibody injection for infants from Sanofi and AstraZeneca.

Portfolio Pulse from Vandana Singh

September 25, 2023 | 11:58 am

BTCUSD

An analyst suggests that Bitcoin's value could surge to over $200,000 if BlackRock's ETF gets approved. The Securities and Exchange Commission (SEC) has delayed its decision on spot bitcoin ETF applications, affecting applicants such as BlackRock, WisdomTree, Invesco Galaxy, Wise Origin, VanEck, Bitwise, and Valkyrie Digital Assets. At the time of writing, BTC was trading at $26,182.36.

Portfolio Pulse from Mehab Qureshi

September 25, 2023 | 11:51 am

NVS

Novartis AG has released topline data from the Phase 3 NETTER-2 trial with Lutathera, a radioligand therapy for advanced gastroenteropancreatic neuroendocrine tumors. The study met its primary endpoint of improvement in progression-free survival and the key secondary endpoint of objective response rate. No new or unexpected safety findings were observed. Morgan Stanley analyst Vincent Meunier upgraded Novartis from Underweight to Equal-Weight.

Portfolio Pulse from Vandana Singh

September 25, 2023 | 11:14 am

MSFT

Guggenheim analyst John Difucci has upgraded Microsoft (NASDAQ:MSFT) from Sell to Neutral.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 10:57 am

UPST

Needham analyst Kyle Peterson has initiated coverage on Upstart Holdings (NASDAQ:UPST) with a Hold rating.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 10:40 am

CFLT

Needham analyst Mike Cikos has reiterated a 'Buy' rating on Confluent (NASDAQ:CFLT) and maintained a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 10:38 am

TSLA

GLJ Research CEO Gordon Johnson, a long-time Tesla Inc bear, predicted a 7% drop in Tesla's sales for the third quarter compared to the second quarter. He also claimed that Tesla's sales are imploding across its three largest markets and its profit margins lag behind competitors. Tesla CEO Elon Musk responded sarcastically, stating that there is value in someone being a reliable contra-indicator. Despite Johnson's predictions, Tesla has consistently reported profits since 2020.

Portfolio Pulse from Anan Ashraf

September 25, 2023 | 10:37 am

DKNG

Needham analyst Bernie McTernan has reiterated a 'Buy' rating on DraftKings (NASDAQ:DKNG) and maintained a price target of $44.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 10:36 am